LeadIQ logo
Learn more at LeadIQ.com

Insights

Rare Disease Focus Generation Bio specializes in genetic medicines for rare and prevalent diseases, presenting sales opportunities in niche markets with high unmet medical needs.

Strategic Partnerships Collaborations with established biotech companies like Moderna highlight Generation Bio's credibility, opening avenues for joint ventures and cross-selling opportunities.

Innovative Technology Stack Utilization of advanced technologies such as SAS, Oracle Cloud, and Nginx indicates a tech-savvy approach that can appeal to clients looking for cutting-edge solutions.

Expanded Manufacturing Capacity Plans to scale manufacturing to produce hundreds of millions of doses indicate growth potential and the ability to cater to larger client demands.

Financial Stability With a revenue range of $10M - $50M and $76M in funding, Generation Bio demonstrates financial stability, reassuring clients of a reliable partner for long-term collaborations.

Similar companies to Generation Bio

Generation Bio Tech Stack

Generation Bio uses 8 technology products and services including SAS, Oracle Cloud, Oracle ERP, and more. Explore Generation Bio's tech stack below.

  • SAS
    Business Intelligence
  • Oracle Cloud
    Data Management Platforms
  • Oracle ERP
    Enterprise
  • RSS
    Miscellaneous
  • PHP
    Programming Languages
  • X-XSS-Protection
    Security
  • Zoom
    Web Conferencing
  • Nginx
    Web Servers

Media & News

Generation Bio's Email Address Formats

Generation Bio uses at least 1 format(s):
Generation Bio Email FormatsExamplePercentage
FLast@generationbio.comJDoe@generationbio.com
49%
Last@generationbio.comDoe@generationbio.com
2%
FLast@generationbio.comJDoe@generationbio.com
49%

Frequently Asked Questions

Where is Generation Bio's headquarters located?

Minus sign iconPlus sign icon
Generation Bio's main headquarters is located at 301 Binney Street 4th Floor Cambridge, Massachusetts 02142 US. The company has employees across 3 continents, including North AmericaAsiaEurope.

What is Generation Bio's stock symbol?

Minus sign iconPlus sign icon
Generation Bio is a publicly traded company; the company's stock symbol is GBIO.

What is Generation Bio's official website and social media links?

Minus sign iconPlus sign icon
Generation Bio's official website is generationbio.com and has social profiles on LinkedIn.

How much revenue does Generation Bio generate?

Minus sign iconPlus sign icon
As of October 2024, Generation Bio's annual revenue reached $35M.

What is Generation Bio's SIC code NAICS code?

Minus sign iconPlus sign icon
Generation Bio's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Generation Bio have currently?

Minus sign iconPlus sign icon
As of October 2024, Generation Bio has approximately 139 employees across 3 continents, including North AmericaAsiaEurope. Key team members include Chief Human Resources Officer: J. T.Chief Financial Officer: M. N.Chief Legal Officer And Corporate Secretary: Y. H.. Explore Generation Bio's employee directory with LeadIQ.

What industry does Generation Bio belong to?

Minus sign iconPlus sign icon
Generation Bio operates in the Biotechnology Research industry.

What technology does Generation Bio use?

Minus sign iconPlus sign icon
Generation Bio's tech stack includes SASOracle CloudOracle ERPRSSPHPX-XSS-ProtectionZoomNginx.

What is Generation Bio's email format?

Minus sign iconPlus sign icon
Generation Bio's email format typically follows the pattern of . Find more Generation Bio email formats with LeadIQ.

How much funding has Generation Bio raised to date?

Minus sign iconPlus sign icon
As of October 2024, Generation Bio has raised $76M in funding. The last funding round occurred on Mar 23, 2023 for $76M.

When was Generation Bio founded?

Minus sign iconPlus sign icon
Generation Bio was founded in 2016.
Generation Bio

Generation Bio

Biotechnology ResearchMassachusetts, United States51-200 Employees

Generation Bio is innovating genetic medicines to provide durable, redosable treatments for people living with rare and prevalent diseases. The company’s non-viral genetic medicine platform incorporates a novel immune-quiet DNA called iqDNA; a unique cell-targeted lipid nanoparticle delivery system, or ctLNP; and a highly scalable capsid-free manufacturing process that uses proprietary cell-free rapid enzymatic synthesis, or RES, to produce iqDNA. This approach is designed to enable multi-year durability from a single dose, to deliver large genetic payloads, including multiple genes, to specific tissues and cell types, and to allow titration and redosing to adjust or extend expression levels in each patient. RES has the potential to expand Generation Bio’s manufacturing scale to hundreds of millions of doses to support its mission to extend the reach of genetic medicine to more people, living with more diseases, around the world. 

Section iconCompany Overview

Headquarters
301 Binney Street 4th Floor Cambridge, Massachusetts 02142 US
SIC Code
8733 - Noncommercial Research Organizations
Stock Symbol
GBIO
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2016
Employees
51-200

Section iconFunding & Financials

  • $76M

    Generation Bio has raised a total of $76M of funding over 5 rounds. Their latest funding round was raised on Mar 23, 2023 in the amount of $76M.

  • $10M$50M

    Generation Bio's revenue is in the range of $10M$50M

Section iconFunding & Financials

  • $76M

    Generation Bio has raised a total of $76M of funding over 5 rounds. Their latest funding round was raised on Mar 23, 2023 in the amount of $76M.

  • $10M$50M

    Generation Bio's revenue is in the range of $10M$50M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.